Description
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Product Unit Size | Cost | Quantity | Stock |
---|
Tyrosinase (369-377) is a tumor antigenic peptide produced by the proteasome that has been used to develop tumor-targeted vaccines with mixed efficacy.
Cas No. | 9002-10-2 |
---|---|
Purity | ≥95% |
Formula | C42H66N10O16S2 |
Formula Wt. | 1031.2 |
Solubility | Soluble in water. |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Guillaume B, Stroobant V, Bousquet-Dubouch MP, et al. Analysis of the processing of seven human tumor antigens by intermediate proteasomes. J Immunol. 2012 Oct 1;189(7):3538-47. PMID: 22925930.
Mitchell MS, Darrah D, Yeung D, et al. Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope. J Clin Oncol. 2002 Feb 15;20(4):1075-86. PMID: 11844833.
Endogenous calcitonin-family peptide, involved ...
PDE3/5 inhibitor, LTD4 antagonist.
Organosulfur found in garlic.
γ-Secretase inhibitor.
Sesquiterpene lactone derived from Artemesia.
Histamine H2 antagonist, GSK-3β inhibitor.
Alkaloid compound originally found in Corydalis...
Geldanamycin derivative; HSP90 inhibitor.
p110δ PI3K inhibitor.
Pesticide; demethylation inhibitor.
Diketopiperazine produced by Aspergillus; micro...
Mixture of oligomycins A, B, C; oxidative phosp...
MDM2 inhibitor.
Nitroimidazole; microtubule polymerization inhi...
Non-steroid; AR antagonist.
HDAC inhibitor, RNA splicing inhibitor.
p38 MAPK inhibitor.
CDK inhibitor.
Casein kinase 1α/δ/ε inhibitor.
Recombinant HCV antigen fragment.